Bangkok--Apr 8--Schering-Plough
To address the serious problem of liver disease and liver cancer in Thailand, Schering-Plough, a leader in the development of chronic viral hepatitis drugs, recently supported the establishment of the Liver Club of Thailand. The Club's aims are to promote an understanding of viral hepatitis -- how it is transmitted and how to avoid contracting it.
Hepatitis is the main cause of liver cancer, one of the most prevalent cancers affecting Thais. Viral hepatitis is also common in other countries in the region, so the Liver Club of Thailand has joined Asia-Hep, a grouping of hepatologists from China, the Philippines, Indonesia, Malaysia, Singapore, India, Korea, Taiwan, Hong Kong, Australia and South Africa. Asia-Hep is supported by Schering-Plough, and its member countries aim is to cooperate on tackling the problem of liver disease.
Pharmacist Wipa Manathanawongsin of Schering-Plough commented: "Exchange of research and knowledge among member countries is very important and to facilitate this, Schering-Plough sponsors meetings each year. This year, the meetings will be held in London, on April 9, and in Bangkok on September 9."
Schering-Plough is also encouraging the general public to become members of the Liver Club. Khun Wipa explained: "One of the basic problems is the lack of awareness about liver disease. Members of the public can help in the fight against viral hepatitis and liver cancer by becoming members and distributing educational materials to their friends and neighbours."
The Liver Club of Thailand can be contacted at its temporary address: c/o Schering-Plough Ltd, 10th Floor Maneeya Centre Building, 518/5 Ploenchit Road, Lumpini, Patumwan, Bangkok 10330. End